Inventor · Lawrence, KS, US

Brian S. J. Blagg

34Patents
10h-index
23Co-inventors
71Inventor score

Filing activity: Oct 27, 2004 → Jul 12, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US7622451B2 Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders Chemistry; Metallurgy 105 Active
US7608594B2 Novobiocin analogues as anticancer agents Human Necessities 105 Expired
US7960353B2 Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders Human Necessities 26 Active
US7208630B2 Heat shock protein 90 inhibitors Chemistry; Metallurgy 26 Expired
US8212012B2 Novobiocin analogues having modified sugar moieties Chemistry; Metallurgy 24 Active
US7811998B2 Novobiocin analogues as anticancer agents Human Necessities 23 Active
US9120774B2 Novobiocin analogues having modified sugar moieties Chemistry; Metallurgy 19 Active
US8212011B2 Novobiocin analogues Chemistry; Metallurgy 19 Active
US9422320B2 C-terminal HSP90 inhibitors Chemistry; Metallurgy 12 Active
US9056104B2 Dynamic inhibitors of heat shock protein 90 Human Necessities 10 Active
US10030041B2 C-terminal Hsp90 inhibitors Chemistry; Metallurgy 8 Active
US10590157B2 C-terminal HSP90 inhibitors Chemistry; Metallurgy 6 Active
US7605288B2 Heat shock protein 90 inhibitors Chemistry; Metallurgy 5 Active
US10030006B2 Coumarin based Hsp90 inhibitors with urea and ether substituents Physics 5 Active
US10590065B2 Biphenyl amides with modified ether groups as HSP90 inhibitors and HSP70 inducers Chemistry; Metallurgy 5 Active
US10745386B2 Coumarin based HSP90 inhibitors with urea and ether substituents Physics 3 Active
US10689344B2 Biphenylamide derivative Hsp90 inhibitors Chemistry; Metallurgy 3 Active
US9994556B2 Triazole modified coumarin and biphenyl amide-based HSP90 inhibitors Chemistry; Metallurgy 3 Active
US11098008B2 Biphenyl amides with modified ether groups as Hsp90 inhibitors and Hsp70 inducers Chemistry; Metallurgy 2 Active
US8188306B2 Heat shock protein 90 inhibitors Chemistry; Metallurgy 2 Active
US9045434B1 Compositions and methods of treatment for myocilin glaucoma by selectively inhibiting GRP94 Human Necessities 2 Active
US10882881B2 C-terminal Hsp90 inhibitors Chemistry; Metallurgy 2 Active
US11318155B2 Hsp90 activator Aha1 drives production of pathological tau aggregates Human Necessities 1 Active
US11708319B2 Biphenyl amides with modified ether groups as HSP90 inhibitors and HSP70 inducers Chemistry; Metallurgy 1 Active
US11390640B2 C-terminal Hsp90 inhibitors Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.